Protective effects of mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: Relevance for myotonic dystrophy 1
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 170, 108030
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- Departament d'Empresa i Coneixement, Generalitat de Catalunya
This publication has 67 references indexed in Scilit:
- Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: A randomized controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Retrospective study on PET–SPECT imaging in a large cohort of myotonic dystrophy type 1 patientsNeurological Sciences, 2010
- Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1ACTA HISTOCHEMICA ET CYTOCHEMICA, 2010
- Evaluating the differential roles of the dorsal dentate gyrus, dorsal CA3, and dorsal CA1 during a temporal ordering for spatial locations taskHippocampus, 2008
- Genetic and Chemical Modifiers of a CUG Toxicity Model in DrosophilaPLOS ONE, 2008
- Cognitive impairment in adult myotonic dystrophies: a longitudinal studyNeurological Sciences, 2007
- Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline TherapyJournal of Immunology Research, 2007
- BrdU assay for neurogenesis in rodentsNature Protocols, 2006
- Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophyThe EMBO Journal, 2000
- Monoamines (norepinephrine, dopamine, serotonin) in the rat medial vestibular nucleus: endogenous levels and turnoverJournal of Neural Transmission, 1996